SC Stays Hearings In HCs On Covid Vaccines, Issues Notices On Pleas Of “Manufacturers”

New Delhi : The Supreme Court on Thursday stayed the ongoing hearing related to COVID-19 vaccines in the Delhi and Bombay High Courts. It also sought responses from the Centre and others on pleas of the Serum Institute and Bharat Biotech seeking transfer of the cases from the high courts to the apex court.

A bench headed by Chief Justice, S A Bobde took note of the pleas of the two firms that the high courts are conducting parallel proceedings on vaccine related issues and they need to be transferred to the top court for an authoritative judgement.

The bench also transferred to itself the vaccine-related case going on in the Delhi High Court.

The vaccine manufacturing firms have said different high courts are seeking data on how many vaccines are produced and when they will give vaccines to all.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs